Modern risk stratification of acute myeloid leukemia in 2023: integrating established and emerging prognostic factors
E Boscaro, I Urbino, FM Catania, G Arrigo, C Secreto… - Cancers, 2023 - mdpi.com
Simple Summary Several factors, both patient-and disease-related, are essential to
accurately estimate acute myeloid leukemia (AML) prognosis. The rapidly evolving field …
accurately estimate acute myeloid leukemia (AML) prognosis. The rapidly evolving field …
The multifaceted roles of cohesin in cancer
M Di Nardo, MM Pallotta, A Musio - Journal of Experimental & Clinical …, 2022 - Springer
The cohesin complex controls faithful chromosome segregation by pairing sister chromatids
after DNA replication until mitosis. In addition, it is crucial for hierarchal three-dimensional …
after DNA replication until mitosis. In addition, it is crucial for hierarchal three-dimensional …
Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication
Core-binding factor (CBF) acute myeloid leukemia (AML) encompasses AML with inv
(16)(p13. 1q22) and AML with t (8; 21)(q22; q22. 1). Despite sharing a common pathogenic …
(16)(p13. 1q22) and AML with t (8; 21)(q22; q22. 1). Despite sharing a common pathogenic …
Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification
T Liu, J Rao, W Hu, B Cui, J Cai, Y Liu, H Sun… - Nature …, 2022 - nature.com
Studies have revealed key genomic aberrations in pediatric acute myeloid leukemia (AML)
based on Western populations. It is unknown to what extent the current genomic findings …
based on Western populations. It is unknown to what extent the current genomic findings …
Proteogenomic analysis reveals cytoplasmic sequestration of RUNX1 by the acute myeloid leukemia–initiating CBFB:: MYH11 oncofusion protein
RB Day, JA Hickman, Z Xu… - The Journal of …, 2024 - Am Soc Clin Investig
Several canonical translocations produce oncofusion genes that can initiate acute myeloid
leukemia (AML). Although each translocation is associated with unique features, the …
leukemia (AML). Although each translocation is associated with unique features, the …
How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML)
In recent years there have been major advances in the use of molecular diagnostic and
monitoring techniques for patients with acute myeloid leukaemia (AML). Coupled with the …
monitoring techniques for patients with acute myeloid leukaemia (AML). Coupled with the …
Cohesin mutations in myeloid malignancies
Cohesin is a multisubunit protein complex that forms a ring-like structure around DNA. It is
essential for sister chromatid cohesion, chromatin organization, transcriptional regulation …
essential for sister chromatid cohesion, chromatin organization, transcriptional regulation …
A genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways that mediate resistance to sorafenib in acute myeloid leukemia
A Damnernsawad, D Bottomly, SE Kurtz… - …, 2020 - pmc.ncbi.nlm.nih.gov
Drug resistance impedes the long-term effect of targeted therapies in acute myeloid
leukemia (AML), necessitating the identification of mechanisms underlying resistance …
leukemia (AML), necessitating the identification of mechanisms underlying resistance …
Unique role of DDX41, a DEAD-box type RNA helicase, in hematopoiesis and leukemogenesis
S Shinriki, H Matsui - Frontiers in oncology, 2022 - frontiersin.org
In myeloid malignancies including acute myeloid leukemia (AML) and myelodysplastic
syndromes (MDS), patient selection and therapeutic strategies are increasingly based on …
syndromes (MDS), patient selection and therapeutic strategies are increasingly based on …
HERC ubiquitin ligases in cancer
J Sala-Gaston, A Martinez-Martinez, L Pedrazza… - Cancers, 2020 - mdpi.com
HERC proteins are ubiquitin E3 ligases of the HECT family. The HERC subfamily is
composed of six members classified by size into large (HERC1 and HERC2) and small …
composed of six members classified by size into large (HERC1 and HERC2) and small …